Pipeline

Antabio portfolio

MEM-PIL

Meropenem-Pilabactam
CRAB,CRE, PA
IV
HAP/VAP

DEVELOPMENT STAGE

DISCOVERY

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3

PEi

Pseudomonas Elastase inhibitorsPA
Inhaled
Chronic respiratory diseases

DEVELOPMENT STAGE

DISCOVERY

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3

AGAR-dp
(Antabio-GARDP discovery platform)

3 projects, novel MoA
IV/Oral stepdown
HAP/VAP, cUTI

DEVELOPMENT STAGE

DISCOVERY

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3

INTABIO-dp
(Antabio internal discovery platform)

1 project, novel target
IV/Oral stepdown
HAP/VAP, cUTI

DEVELOPMENT STAGE

DISCOVERY

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3